Home  /   Products  /   Nervous system  /   Peppermint oil, ethylbromisovalerinate, motherwort herba (Corvalol Phyto) – [50 tablets]

Peppermint oil, ethylbromisovalerinate, motherwort herba (Corvalol Phyto) – [50 tablets]


Sedative agent

SKU: 61793 Category:


Corvalol Phyto Pharmacodynamics
A combination drug, the action of which is due to the properties of its constituent substances. It has sedative and antispasmodic effects, moderate cardiotonic effect (slows rhythm and increases strength of heart contractions), has moderate hypotensive properties.
Ethylbromizovalerianat has sedative and antispasmodic effect caused by irritation, mainly of receptors in the mouth and nasopharynx, reducing reflex excitability in the central nervous system and increased inhibition in the cortex and subcortical neurons of the brain, as well as reducing the activity of central vasomotor centers and a direct local spasmolytic effect on smooth muscles.
Motherwort herb has a pronounced sedative (sedative), moderate cardiotonic (slows rhythm and increases the force of heart contractions), moderate hypotensive effect.
Peppermint oil has a reflex vasodilatory, antispasmodic, mild choleretic, antiseptic action. The mechanism of action is related to the ability to irritate the “cold” receptors of the mucous membrane of the mouth and expand reflexively mainly vessels of the heart and brain. It eliminates the phenomena of flatulence by irritating the mucous membrane receptors of the gastrointestinal tract (GIT), increasing intestinal peristalsis.

Sleep disorders, neurosis-like conditions, accompanied by increased irritability and excitability, agitation with marked autonomic manifestations, as antispasmodic agent – in intestinal spasms, as well as symptomatic (sedative and vasodilator) means in functional disorders of the cardiovascular system.

– Hypersensitivity to the components of the drug;
– Severe renal and/or hepatic impairment;
– pregnancy;
– period of lactation (breast-feeding);
– children under 18 years of age (efficacy and safety have not been established);
– lactose intolerance, lactase deficiency, glucose-galactose malabsorption.
If you have one of the following diseases/conditions, be sure to consult your doctor before taking the drug.
Impaired renal and/or liver function.
Pregnancy and lactation:
The safety of use of the drug Corvalol Fito, tablets in pregnancy has not been established, the use of the drug during pregnancy is contraindicated.
There is no data on penetration of the drug components into the breast milk, so if it is necessary to use the drug during lactation, the question of stopping breastfeeding should be solved.

Directions for use and dosages.

  • To be taken orally, before meals, with water.
  • For tablets, 0.58 mg + 14.00 mg + 8.20 mg: adults 2 tablets 2 times a day.
  • For tablets, 1.16 mg + 28.00 mg + 16.40 mg: adults 1 tablet 2 times a day.
  • In case of tachycardia, the single dose may be increased to 3 tablets. The maximum daily dose is 6 tablets.
  • The course of treatment is 4 weeks (28 days). The duration of treatment may be increased upon the doctor’s recommendation.